NSCLC With M7824 Second Line Therapy

NSCLC With M7824 Second Line Therapy

Cancer-News

1 year
44 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Byoung Chul Cho, M.D., Yonsei Cancer Center discusses NSCLC With M7824 Second Line Therapy. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
Up Next Autoplay